Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.83 USD
Change Today -0.047 / -5.34%
Volume 111.9K
DCTH On Other Exchanges
Symbol
Exchange
DCTH is not on other exchanges.
As of 5:20 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eamonn P. Hobbs

Former Chief Executive Officer, President and Director, Delcath Systems, Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 8 different industries.

See Board Relationships
55$2,020,175
As of Fiscal Year 2013

Background*

Mr. Eamonn P. Hobbs has been the Chief Executive Officer and President of Antares Pharma Inc., since June 23, 2014. Mr. Hobbs served as the Chief Executive Officer and President of Delcath Systems, Inc. from July 2009 to September 10, 2013. He Co-founded AngioDynamics Inc., a subsidiary of E-Z-EM Inc. and served as its Chief Executive Officer and President from June 1996 to March 1, 2009. He served as Senior Vice President of Angio Dynamics since October 2002 and its ...

Read Full Background

Corporate Headquarters*

1301 Avenue of the Americas
New York, New York 10019

United States

Phone: 212-489-2100
Fax: 212-489-2102

Board Members Memberships*

Former Vice Chairman of the Board
Vice Chairman
Board Chair
Director
Former Chairman
2008-2013
Former Chief Executive Officer, President and Director
2009-Present
Chief Executive Officer, President and Director
2010-Present
Chairman
2014-Present
Chairman

Education*

BS 1980
University of Massachusetts Lowell

Other Affiliations*

Annual Compensation*

Salary$292,923
Total Annual Compensation$292,923

Stock Options*

Restricted Stock Awards$798,300
All Other Compensation$40,524
Exercisable Options213,333
Exercisable Options Value$128,900
Unexercisable Options416,667
Total Value of Options$128,900
Total Number of Options630,000

Total Compensation*

Total Annual Cash Compensation$359,875
Total Short Term Compensation$292,923
Other Long Term Compensation$838,824
Total Calculated Compensation$2,020,175
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DCTH:US $0.83 USD -0.047

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$520.8K
Caren L. Mason Chief Executive Officer, President, Director and Chairman of Quality & Regulatory Committee
STAAR Surgical Company
--
Jeffrey M. Nugent Chief Executive Officer, President, Director and Member of Finance Committee
BIOLASE, Inc.
$150.0K
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$443.7K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELCATH SYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.